Cubist Systematic Strategies’s Immunocore IMCR Stock Holding History
Bought
Maintained
Sold
Other funds holding IMCR
RI
BG
BBA
TCM
DTC
BI
Cubist Systematic Strategies's IMCR Position: Q3 2025 in Review
Cubist Systematic Strategies reduced its Immunocore (IMCR) stake by 52% in Q3 2025, selling an estimated $2.52M and leaving 68,572 shares worth $2.49M. The position accounts for 0.01% of the portfolio, ranked #1427.
Cubist Systematic Strategies first reported a position in IMCR in Q3 2021 and has held it in 15 quarters since. The position peaked at $4.79M in Q4 2022. 132 funds tracked by Wall St. Rank hold IMCR as of Q3 2025.
- Cubist Systematic Strategies held 68,572 shares of Immunocore worth $2.49M as of Q3 2025.
- Cubist Systematic Strategies sold 74,185 Immunocore shares in Q3 2025, an estimated $2.52M.
- Immunocore made up 0.01% of Cubist Systematic Strategies's portfolio in Q3 2025, its #1427 holding.
- Cubist Systematic Strategies first reported a position in Immunocore in Q3 2021 and has held it in 15 quarters since.
- Cubist Systematic Strategies's Immunocore position peaked at $4.79M in Q4 2022.
- 132 funds tracked by Wall St. Rank held Immunocore as of Q3 2025.
Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.